Usefulness of systematic chromoendoscopy with a double dye staining technique for the detection of dysplasia in patients with premalignant gastric lesions;Utilidad de la endoscopia sistemática con bicromoendoscopia para la detección de displasia en pacientes con lesiones premalignas gástricas

Gastroenterologia y Hepatologia

Volumn 39, Issue 2, 2016, Pages 49-54

  Yep Gamarra, Víctor ^a   Díaz Vélez, Cristian ^b   Araujo, Isis ^c   Ginès, Àngels ^c   Fernández Esparrach, Gloria ^c  

^a HOSPITAL REGIONAL LAMBAYEQUE   (Peru)

^b UNIVERSIDAD DE SAN MARTÍN DE PORRES   (Peru)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Chromoendoscopy; Dysplasia; Gastric atrophy; Gastric cancer; Intestinal metaplasia; Premalignant lesions; Screening

Indexed keywords

ACETIC ACID; INDIGO CARMINE;

ARTICLE; CHROMOENDOSCOPY; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE DYE STAINING; GASTRIC MUCOSA; GASTROINTESTINAL DYSPLASIA; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LONGITUDINAL STUDY; PHOTOGRAPHY; PRECANCER; PROSPECTIVE STUDY; STAINING; STOMACH ATROPHY; STOMACH BIOPSY; STOMACH LESION; TOPOGRAPHY; DIAGNOSTIC IMAGING; ENDOSCOPY; PRECANCEROUS CONDITIONS; PROCEDURES; STOMACH MUCOSA; STOMACH NEOPLASMS;

ENDOSCOPY; GASTRIC MUCOSA; HUMANS; INDIGO CARMINE; LONGITUDINAL STUDIES; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; STAINING AND LABELING; STOMACH NEOPLASMS;

EID: 84960291522     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2015.08.005     Document Type: Article

References (30)

1. Chey W., Wong B.C. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J. Gastroenterol 2007, 102:1808-1825. Practice Parameters Committee of the American College of Gastroenterology.
2. Luther J., Chey W. Sequential therapy for Helicobacter Pylori: A two for one deal thats worth the extra effort. Gastroenterology 2009, 136:720-721.
3. Menon S., Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open 2014, 02:E46-E50.
4. Dinis-Ribeiro M., Areia M., de Vries A.C., Marcos-Pinto R., Monteiro-Soares M., O'Connor A., et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012, 44:74-94.
5. De Vries A., van Grieken N., de Vries C., Looman S., Meijer G., Kuipers E. Gastric cancer risk in patients with premalignant gastric lesions:A nationwide cohort study in the Netherlands. Gastroenterology 2008, 134:945-952.
6. Sharaf R.N., Shergill A.K., Odze R.D., Krinsky M.L., Fukami N., Jain R., et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc 2013, 78:216-224. ASGE Standards of Practice Committee.
7. Kapadia C.R. Gastric atrophy, metaplasia and dysplasia. A clinical perspective. J Clin Gastroenterol 2003, 36:29-36.
8. Hosokawa O., Watanabe K., Hatorri M., Douden K., Hayashi H., Kaizaki Y. Detection of gastric cancer by repeat endoscopy within a short time after negative examination. Endoscopy 2001, 33:301-305.
9. Cho Y.S., Chung I.K., Kim J.H., Jung Y., Lee T.H., Park S.H., et al. Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci 2015, 60:936-943.
10. Simone A., Casadei A., de Vergori E., Morgagni P., Saragoni L., Ricci E. Rescue endoscopy to identify site of gastric dysplasia or carcinoma found at random biopsies. Dig Liver Dis 2011, 43:721-725.
11. Chang C.C., Chen S.H., Lin C.P., Hsieh C.R., Lou H.Y., Suk F.M., et al. Premedication with pronase or N-acetylcysteine improves visibility during gastroendoscopy: An endoscopist-blinded, prospective, randomized study. World J Gastroenterol 2007, 13:444-447.
12. Teh J.L., Hartman M., Lau L., Tan J.R., Wong A., Ng J.J., et al. Duration of endoscopic examination significantly impacts detection rates of neoplastic lesions during diagnostic upper endoscopy. Gastrointest Endosc 2011, 73:AB393.
13. Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol 2013, 26:11-22.
14. Trivedi P.J., Braden B. Indications, stains and techniques in chromoendoscopy. QJM 2013, 106:117-131.
15. Yamashita H., Kitayama J., Ishigami H., Yamada J., Miyato H., Kaisaki S., et al. Endoscopic instillation of indigo carmine dye with acetic acid enables the visualization of distinct margin of superficial gastric lesion; usefulness in endoscopic treatment and diagnosis of gastric cancer. Dig Liver Dis 2007, 39:389-391.
16. Sakai Y., Eto R., Kasanuki J., Kondo F., Kato K., Arai M., et al. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of gastric neoplasia: a prospective comparative study. Gastrointest Endosc 2008, 68:635-641.
17. Xueling L., Sha J., Li L., Shi R. Chromoendoscopy with indigo carmine dye added to acetic acid in the diagnosis of early gastric cancer and precancerous. Gastrointest Endosc 2011, 73:AB255.
18. Dinis-Ribeiro M. Chromoendoscopy for early diagnosis of gastric cancer. Eur J Gastroenterol Hepatol 2006, 18:831-838.
19. Hoffman A., Korczynski O., Tresch A., Hansen T., Rahman F., Goetz M., et al. Acetic acid compared with i-scan imaging for detecting Barrett's esophagus: a randomized, comparative trial. Gastrointest Endosc 2014, 79:46-54.
20. Lee B.E., Kim G.H., Park do Y., Kim D.H., Jeon T.Y., Park S.B., et al. Acetic acid-indigo carmine chromoendoscopy for delineating early gastric cancers: its usefulness according to histological type. BMC Gastroenterol 2010, 10:97.
21. Kawahara Y., Takenaka R., Kato J., Imagawa A., Okada H., Shiratori Y. A novel chromoendoscopic method by using acetic acid-indigo carmine mixture (AIM) for diagnosis of early gastric cancers. Gastrointest Endosc 2006, 63:AB249.
22. Capelle L.G., de Vries A.C., Haringsma J., Ter Borg F., de Vries R.A., Bruno M.J., et al. The staging of gastritis with the OLGA system by using intestinalmetaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010, 71:1150-1158.
23. De Vries A.C., Haringsma J., de Vries R.A., Ter Borg F., van Grieken N.C., Meijer G.A., et al. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 2010, 15:259-264.
24. Singla M., Armbruster S., Shah N., Burman M., Maydonovitch C., Young P.E., et al. Topographical mapping in a cohort of patients with gastric intestinal metaplasia. Am J Gastroenterol 2014, 109:S46.
25. Cappelle L., Harigsma J., de Vries A.C., Steyerberg E.W., Biermann K., van Dekken H., et al. Narrow band imaging for detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Dig Dis Sci 2010, 10:1089-1092.
26. Bray F., Ren J.S., Masuyer E., Ferlay J. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013, 132:1133-1145.
27. Mendoza D., Herrera P., Gilman R.H., Lanfranco J., Tapia M., Bussalleu A. Variation in the prevalence of gastric cancer in Peru. Int J Cancer 2008, 123:414-420.
28. Rex D.K., Petrini J.L., Baron T.H., Chak A., Cohen J., Deal S.E., et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006, 101:873-885.
29. Teh J.L., Tan J.R., Lau L.J., Saxena N., Salim A., Tay A., et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2015, 13:480-487.
30. Rollán A., Cortés P., Calvo A., Araya R., Bufadel M.E., González R., et al. Diagnóstico precoz de cáncer gástrico. Propuesta de detección y seguimiento de lesiones premalignas gástricas: protocolo ACHED. Rev Med Chile 2014, 142:1181-1192.